Greg Mushen: Even Quantum Breakthroughs Can't Flatten Drug Discovery's Empirical Bottleneck
gregmushen · x · 2026-10-13
Commenting on quantum tech for AI drug discovery, Greg Mushen argues that even if quantum sensing delivers 1,000,000x more biological-state information and quantum simulation vastly improves predictions, verifying that predictions hold in humans remains logically distinct. Moreover, since building prediction and validation systems requires iterative trips through empirical feedback, the realized curves for prediction and clinical validation stay substantially flatter even if the underlying technologies scale exponentially.
More from AGI Musings
- Tech people will never have taste? The AI 'soulfulness' discourse kicks off — basedjensen · 2026-10-13
- MIT's Cyborg Psychology explains: Cyborg vs Android vs Humanoid AI — patpat_mit · 2026-10-13
- The forgotten history of IA: Licklider and Engelbart's case for augmenting humans — patpat_mit · 2026-10-13
- Born for space: how the 1960 Clynes-Kline paper coined the 'cyborg' — patpat_mit · 2026-10-13
- TechCrunch visits MIT's Cyborg Psychology: why we can't help treating AI like humans — patpat_mit · 2026-10-13
- Tim Hwang: self-driving research fields in silico are on the edge of reality — CatAstro_Piyush · 2026-10-13